Speakers
Sheldon Cao, Ph.D., CEO, Zova Biotherapeutics, Inc.
Daniel Christ, Ph.D., Associate Professor & Head, Antibody Therapeutics, Immunology Program, Garvan institute of Medical Research, Australia
Dimiter Dimitrov, Ph.D., Senior Investigator, NCI, National Institutes of Health
Riley Ennis, MSc, Thiel Fellow, Cell and Molecular Biology, Dartmouth College
Changshou Gao, Ph.D., Fellow, R&D, Department of Antibody Discovery & Protein Engineering, MedImmune, LLC.
Chandrashekar Ganesa, Ph.D., Senior Director, Analytical Development, Global Biotherapeutics, Sanofi
Jinming Gu, Ph.D., Senior Scientist, Global Biologics, Abbvie, Inc.
Bruce Nianhe Han, Ph.D., CSO, Research & Development, NewBio Therapeutics, PR China
Markus Haindl, Ph.D., Director, Development Analytics, Roche Diagnostics GmbH, Germany
Yuji Hori, Ph.D., Research Scientist, Chugai Pharmaceutical, Japan
Simon E. Hufton, Ph.D., Principal Scientist, Biotherapeutics, National Institute for Biological Standards and Control (NIBSC)
Darshana Jani, Ph.D., Senior Manager, Clinical Assay Group, Global Innovation Pharma, Pfizer, Inc.
Weidong Jiang, Ph.D., CSO, Henlius Biopharmaceuticals, Inc.
Syd Johnson, Ph.D., Vice President, Antibody Engineering, MacroGenics, Inc.
Robb Kahn, M.D., Senior Safety Science Leader, Global Pediatric Oncology Drug Development, Genentech, a member of the Roche Group
Jochen Kruip, Ph.D., Department Head, BioInnovation Novel Therapeutic Protein Formats, Sanofi
Jonathan R. Lai, Ph.D., Associate Professor, Biochemistry, Albert Einstein College of Medicine
Kedan Lin, Ph.D., Senior Scientist, Therapeutic Area Lead for Oncology Large Molecules, Pharmacokinetics & Pharmacodynamics, Genentech, Inc.
Jun Liu, Ph.D., Director, Therapeutic Proteins, Biologics & Biotechnology Department, USP China
Stephen Mahler, Ph.D., Professor, Australian Institute for Bioengineering and Nanotechnology, University of Queensland
A. Scott Muerhoff, Ph.D., Director, Biologics Discovery and Design, Abbott Diagnostics
Bilikallahalli Muralidhara, Ph.D., Associate Director, Vaccines & Biologics, Biopharmaceutical Development, MedImmune, Inc.
Masaru Muraoka, Ph.D., Research Scientist, Discovery Research Department, Chugai Pharmaceutical Co., Ltd., Japan
Johan Nilvebrant, Ph.D., Postdoctoral Researcher, The Donnelly Centre, Center for Cellular and Biomolecular Research, University of Toronto, Canada
Andreas Pahl, Ph.D., CSO, Heidelberg Pharma GmbH
Thomas Pillow, Ph.D., Scientist, Discovery Chemistry, Genentech, Inc.
Jaume Pons, Ph.D., Senior Vice President and CSO, Rinat- Pfizer
Wei Qi, Senior Scientist, Bioscience Initiative, Malvern Instruments Inc
Xueming Qian, Ph.D., Chairman and CEO, Mabspace Biosciences, Co. Ltd., PR China
Hong Qin, M.D., Ph.D., Assistant Professor, Lymphoma & Myeloma, MD Anderson Cancer Center
Gayathri Ratnaswamy, Ph.D., Director, Analytical & Formulation, Agensys, Inc.
Aaron Sato, Ph.D., Vice President, Research, Sutro Biopharma, Inc.
Jonas V. Schaefer, Ph.D., Head, High-Throughput Laboratory, Department of Biochemistry, University of Zurich, Switzerland
Satish K. Singh, Ph.D., Research Fellow, Biotherapeutics Pharmaceutical Sciences, Pfizer, Inc.
Arne Skerra, Ph.D., Professor, Technische Universität München; Founder, Pieris AG, Germany
Haijun Sun, Ph.D., Vice President, Tumor Biology and Protein Sciences, F-Star Biotechnology, United Kingdom
Bailin Tu, Ph.D., Principal Scientist, Biologics Discovery and Design, Abbott Laboratories
Wei Wang, Ph.D., Research Fellow, Pharmaceutical R&D, Pfizer, Inc.
John C. Williams, Ph.D., Associate Professor, Molecular Medicine, Beckman Research Institute at City of Hope
Chengbin Wu, Ph.D., President, R&D and CSO, Shanghai C.P. Guojian Pharamceutical Co. Ltd., PR China
Lihui Xu, Antibody Technology, Merrimack Pharmaceuticals
Tianlei Ying, Ph.D., Head, Antibody Engineering and Drug Discovery Group, School of Basic Medical Science, Fudan University
Wei Yan, Ph.D., Director, Research, Therapeutic Discovery, Amgen, Inc.
Jia-Ming Yang, Ph.D., Senior Scientist, Analytical Development, Livzon MabPharm Inc., PR China
Jin-San Yoo, Ph.D., President & CEO, PharmAbcine, Inc., Korea
Michelle Yuqing Shen, M.D., MSc., MBA, Senior Scientist, Amgen China R&D
Qi Zeng, Ph.D., Associate Professor, Institute of Molecular and Cell Biology (IMCB), Singapore
XiaoYing Zhang, Ph.D., Professor, Veterinary Pharmacology, College of Veterinary Medicine, Northwest A&F University
Marie Zhu, Ph.D., Director, Process Sciences, Agensys, Inc./Astellas, Inc.
Zhenping Zhu, Ph.D., Executive Vice President, Global Biopharmaceuticals, Kadmon Corporation